JP2022504620A5 - - Google Patents
Info
- Publication number
- JP2022504620A5 JP2022504620A5 JP2021519726A JP2021519726A JP2022504620A5 JP 2022504620 A5 JP2022504620 A5 JP 2022504620A5 JP 2021519726 A JP2021519726 A JP 2021519726A JP 2021519726 A JP2021519726 A JP 2021519726A JP 2022504620 A5 JP2022504620 A5 JP 2022504620A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- oxo
- methyl
- triazine
- dione
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024204381A JP2025041602A (ja) | 2018-10-12 | 2024-11-25 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862745195P | 2018-10-12 | 2018-10-12 | |
| US62/745,195 | 2018-10-12 | ||
| PCT/US2019/055689 WO2020077123A1 (en) | 2018-10-12 | 2019-10-10 | Thyroid hormone receptor beta agonist compounds |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024204381A Division JP2025041602A (ja) | 2018-10-12 | 2024-11-25 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022504620A JP2022504620A (ja) | 2022-01-13 |
| JP2022504620A5 true JP2022504620A5 (https=) | 2022-10-13 |
| JP7595004B2 JP7595004B2 (ja) | 2024-12-05 |
Family
ID=70161488
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021519726A Active JP7595004B2 (ja) | 2018-10-12 | 2019-10-10 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
| JP2024204381A Pending JP2025041602A (ja) | 2018-10-12 | 2024-11-25 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024204381A Pending JP2025041602A (ja) | 2018-10-12 | 2024-11-25 | 甲状腺ホルモン受容体ベータアゴニスト化合物 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US11203587B2 (https=) |
| EP (1) | EP3863635A4 (https=) |
| JP (2) | JP7595004B2 (https=) |
| CN (1) | CN112839655B (https=) |
| AR (1) | AR116694A1 (https=) |
| AU (1) | AU2019357618B2 (https=) |
| CA (1) | CA3114015A1 (https=) |
| MA (1) | MA53868A (https=) |
| TW (2) | TWI884745B (https=) |
| WO (1) | WO2020077123A1 (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| KR20220017917A (ko) | 2019-05-08 | 2022-02-14 | 알리고스 테라퓨틱스 인코포레이티드 | Thr-베타의 조절제 및 이의 사용 방법 |
| AU2020336272A1 (en) | 2019-08-23 | 2022-04-14 | Terns Pharmaceuticals, Inc. | Thyroid hormone receptor beta agonist compounds |
| WO2021050945A1 (en) | 2019-09-12 | 2021-03-18 | Terns, Inc. | Thyroid hormone receptor beta agonist compounds |
| CN113278013B (zh) * | 2020-02-20 | 2022-09-23 | 昆药集团股份有限公司 | 2,6-二取代的1,2,4-三嗪-3,5-二酮化合物及其制备方法和应用 |
| US20230257367A1 (en) * | 2020-06-02 | 2023-08-17 | Chengdu Kanghong Pharmaceutical Co., Ltd. | Novel thyroid hormone beta receptor agonist |
| WO2022053028A1 (zh) * | 2020-09-10 | 2022-03-17 | 南京明德新药研发有限公司 | 1,2,4-三嗪-3,5(2h,4h)-二酮类化合物及其应用 |
| CN112645936B (zh) * | 2020-12-17 | 2022-03-01 | 山东第一医科大学(山东省医学科学院) | 取代的哒嗪酮类化合物及其用途 |
| PE20240097A1 (es) * | 2021-03-03 | 2024-01-18 | Terns Pharmaceuticals Inc | Compuestos agonistas beta del receptor de la hormona tiroidea |
| EP4568664B1 (en) | 2023-04-07 | 2026-04-01 | Terns Pharmaceuticals, Inc. | Combination comprising a thr-beta agonist and a glp-1r agonist for use in treating obesity |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2240017T3 (es) | 1999-09-30 | 2005-10-16 | Pfizer Products Inc. | Derivados de 6-azauracilo como ligandos de receptores tiroideos. |
| US6787652B1 (en) | 1999-09-30 | 2004-09-07 | Pfizer, Inc. | 6-Azauracil derivatives as thyroid receptor ligands |
| EP1471049A4 (en) | 2002-01-30 | 2006-08-16 | Kissei Pharmaceutical | NEW THYROIDIAN HORMONE RECEPTOR LIGAND, MEDICINAL PREPARATIONS CONTAINING THE SAME AND USE THEREOF |
| WO2003094845A2 (en) | 2002-05-08 | 2003-11-20 | Bristol-Myers Squibb Company | Pyridine-based thyroid receptor ligands |
| US7572799B2 (en) | 2003-11-24 | 2009-08-11 | Pfizer Inc | Pyrazolo[4,3-d]pyrimidines as Phosphodiesterase Inhibitors |
| FR2882750B1 (fr) | 2005-03-03 | 2007-05-11 | Pierre Fabre Medicament Sa | Derives de 1,2,4-triazines, leur preparation et leur application en therapeutique humaine |
| GB0513692D0 (en) | 2005-07-04 | 2005-08-10 | Karobio Ab | Novel pharmaceutical compositions |
| DK1919878T3 (da) * | 2005-07-21 | 2010-10-25 | Hoffmann La Roche | Pyridazinonderivater som thyroidhormonreceptoragonister |
| FR2933979B1 (fr) | 2008-07-15 | 2012-08-24 | Pf Medicament | Derives de triazines et uraciles, leur preparation et leur application en therapeutique humaine |
| RU2527948C2 (ru) | 2009-04-20 | 2014-09-10 | Мицубиси Танабе Фарма Корпорейшн | Новый агонист бета рецептора тиреоидного гормона |
| WO2011038207A1 (en) | 2009-09-25 | 2011-03-31 | Metabasis Therapeutics, Inc. | Phosphorus-containing thyroid hormone receptor agonists and methods of use |
| SG11201402004YA (en) * | 2011-11-14 | 2014-05-29 | Cephalon Inc | Uracil derivatives as axl and c-met kinase inhibitors |
| CN103130723B (zh) | 2011-11-30 | 2015-01-14 | 成都地奥制药集团有限公司 | 一种多聚(adp-核糖)聚合酶抑制剂 |
| CN107074823B (zh) * | 2014-09-05 | 2021-05-04 | 基因泰克公司 | 治疗性化合物及其用途 |
| WO2018075650A1 (en) | 2016-10-18 | 2018-04-26 | Madrigal Pharmaceuticals, Inc. | Methods of treating liver disorders or lipid disorders with a thr-beta agonist |
| JP7156722B2 (ja) | 2018-01-23 | 2022-10-19 | 深▲チェン▼市塔吉瑞生物医薬有限公司 | 置換ピリダジノン化合物 |
| ES3029158T3 (en) | 2018-06-12 | 2025-06-23 | Xizang Haisco Pharmaceutical Co Ltd | Thyroid hormone receptor agonists and uses thereof |
| CN112805005A (zh) | 2018-08-24 | 2021-05-14 | 拓臻股份有限公司 | 甲状腺素受体β促效剂化合物 |
| CA3113373A1 (en) | 2018-10-12 | 2020-04-16 | InventisBio Co., Ltd. | Thyroid hormone receptor agonists |
| CN111320609A (zh) | 2018-12-13 | 2020-06-23 | 拓臻股份有限公司 | 一种THRβ受体激动剂化合物及其制备方法和用途 |
| CN111484481A (zh) | 2019-01-26 | 2020-08-04 | 察略盛医药科技(上海)有限公司 | 哒嗪酮类衍生物、其制备方法及其在医药上的用途 |
| CN113474335B (zh) | 2019-02-21 | 2024-12-03 | 南京瑞捷医药科技有限公司 | 化合物及其作为甲状腺激素受体激动剂的用途 |
| WO2020239076A1 (zh) | 2019-05-29 | 2020-12-03 | 南京明德新药研发有限公司 | 作为甲状腺素受体-β激动剂的哒嗪酮类衍生物及其应用 |
-
2019
- 2019-10-09 TW TW113111231A patent/TWI884745B/zh active
- 2019-10-09 TW TW108136747A patent/TWI840423B/zh active
- 2019-10-10 AU AU2019357618A patent/AU2019357618B2/en active Active
- 2019-10-10 US US16/598,978 patent/US11203587B2/en active Active
- 2019-10-10 EP EP19870196.3A patent/EP3863635A4/en active Pending
- 2019-10-10 JP JP2021519726A patent/JP7595004B2/ja active Active
- 2019-10-10 MA MA053868A patent/MA53868A/fr unknown
- 2019-10-10 CN CN201980067301.7A patent/CN112839655B/zh active Active
- 2019-10-10 WO PCT/US2019/055689 patent/WO2020077123A1/en not_active Ceased
- 2019-10-10 CA CA3114015A patent/CA3114015A1/en active Pending
- 2019-10-11 AR ARP190102912A patent/AR116694A1/es unknown
-
2022
- 2022-06-30 US US17/855,672 patent/US20220348561A1/en not_active Abandoned
-
2024
- 2024-11-25 JP JP2024204381A patent/JP2025041602A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022504620A5 (https=) | ||
| JP2022544714A5 (https=) | ||
| CN115734966A (zh) | 杂环化合物及其用途 | |
| WO2018013597A4 (en) | 2,5-disubstituted 3-methyl pyrazines and 2,5,6-trisubstituted 3-methyl pyrazines as allosteric shp2 inhibitors | |
| JP2020536881A5 (https=) | ||
| RU2655914C2 (ru) | Соединения дигидропиримидина и их применение в фармацевтических препаратах | |
| JP2021535207A5 (https=) | ||
| JP2020527588A5 (https=) | ||
| JP2021534124A5 (https=) | ||
| JP2014509647A5 (https=) | ||
| JP2022512482A5 (https=) | ||
| TWI801517B (zh) | 經取代的2-吡啶酮三環化合物、其類似物及其使用方法 | |
| JP2021500394A5 (https=) | ||
| JP7811768B2 (ja) | ピロール化合物 | |
| CN114222740A (zh) | 新型极光激酶抑制剂及其用途 | |
| JP2022548250A5 (https=) | ||
| JP2021514001A5 (https=) | ||
| RU2011147232A (ru) | Производное карбоновой кислоты | |
| JP2016505619A5 (https=) | ||
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| JP2015516420A5 (https=) | ||
| JP2015514063A5 (https=) | ||
| JP2023531709A5 (https=) | ||
| JP2016503785A5 (https=) | ||
| JP2017529389A5 (https=) |